BIOREGENX, INC. financial metrics

Latest SEC-reported values and YoY changes across profitability, balance sheet, and share metrics. Latest period: Q3 2025.

Symbol
BRGX on OTC
Location
Chattanooga, TN
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key metrics snapshot

Net Income (Loss) Attributable to Parent

$18,926,335

YoY: -285%

View history

Profitability, Liquidity & Leverage Ratios

Metric Latest value YoY change
Current Ratio 7.4% -47%
Quick Ratio 3.2% -42%
Debt-to-equity -123% -461%
Return On Equity 532%
Return On Assets -2288% -6275%
Operating Margin -965% -430%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 961,992,601 0.57%
Common Stock, Shares, Outstanding 961,992,601 0.57%
Common Stock, Value, Issued $961,993 0.57%
Weighted Average Number of Shares Outstanding, Basic 960,873,144 0.45%
Weighted Average Number of Shares Outstanding, Diluted 960,873,144 0.45%

Income Statement

Metric Latest value YoY change
Revenues $1,929,361 -25%
Cost of Revenue $421,740 -50%
Research and Development Expense $33,036 -168%
Operating Income (Loss) $18,625,148 -300%
Earnings Per Share, Basic 0 -100%
Earnings Per Share, Diluted 0 -100%
Net Income (Loss) Attributable to Parent $18,926,335 -285%

Balance Sheet

Metric Latest value YoY change
Accounts Receivable, after Allowance for Credit Loss, Current $62,610 222%
Inventory, Net $109,378 -31%
Other Assets, Current $49,057 -33%
Assets, Current $273,156 -26%
Property, Plant and Equipment, Net $169,608 -20%
Assets $1,167,764 -93%
Accounts Payable, Current $459,652 -6.7%
Accrued Liabilities, Current $380,599 -11%
Liabilities, Current $3,933,831 12%
Liabilities $4,814,900 27%
Retained Earnings (Accumulated Deficit) $36,097,759 -110%
Stockholders' Equity Attributable to Parent $3,647,136 -127%
Liabilities and Equity $1,167,764 -93%

Additional Metrics

Metric Latest value YoY change
Common Stock, Shares Authorized 1,500,000,000 0%
Common Stock, Shares, Issued 961,992,601 0.57%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $46,947 -33%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $18,924,391 -285%
Additional Paid in Capital $31,488,626 5.7%
Interest Expense $72,106 6.7%